Involvement of miR-29b signaling in the sensitivity to chemotherapy in patients with ovarian carcinoma

Human Pathology

Volumn 45, Issue 6, 2014, Pages 1285-1293

  Dai, Furong ^a   Zhang, Yi ^a   Chen, Yuxiang ^a  

^a CENTRAL SOUTH UNIVERSITY   (China)

Author keywords

ATG9A; MAPK10; Mcl1; miR 29b; Ovarian cancer; Overall survival; Progression free survival

Indexed keywords

AUTOPHAGY RELATED PROTEIN 9; CISPLATIN; CYCLOPHOSPHAMIDE; MESSENGER RNA; MICRORNA 29B; MITOGEN ACTIVATED PROTEIN KINASE 10; MYELOID LEUKEMIA FACTOR 1; PACLITAXEL; PROTEIN; PROTEIN MCL 1; UNCLASSIFIED DRUG;

ARTICLE; CANCER CHEMOTHERAPY; CANCER GRADING; CANCER PATIENT; CANCER RECURRENCE; CANCER STAGING; CANCER SURVIVAL; CHEMOSENSITIVITY; CLEAR CELL CARCINOMA; DOWN REGULATION; FEMALE; GENE EXPRESSION; GENE TARGETING; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MAJOR CLINICAL STUDY; OVARY ADENOCARCINOMA; OVARY CARCINOMA; OVERALL SURVIVAL; PROGRESSION FREE SURVIVAL; REAL TIME POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION;

ATG9A; MAPK10; MCL1; MIR-29B; OVARIAN CANCER; OVERALL SURVIVAL; PROGRESSION-FREE SURVIVAL;

ADENOCARCINOMA; DISEASE-FREE SURVIVAL; DRUG RESISTANCE, NEOPLASM; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; KAPLAN-MEIER ESTIMATE; MEMBRANE PROTEINS; MICRORNAS; MITOGEN-ACTIVATED PROTEIN KINASE 10; OVARIAN NEOPLASMS; PROPORTIONAL HAZARDS MODELS; REAL-TIME POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION;

EID: 84901465851     PISSN: 00468177     EISSN: 15328392     Source Type: Journal    
DOI: 10.1016/j.humpath.2014.02.008     Document Type: Article

References (28)

1. D. Van Simaeys, D. López-Colón, K. Sefah, R. Sutphen, E. Jimenez, and W. Tan Study of the molecular recognition of aptamers selected through ovarian cancer cell-SELEX PLoS One 5 2010 e13770
2. P. Hartge Designing early detection programs for ovarian cancer J Natl Cancer Inst 102 2010 3 4
3. L.J. Willmott, and J.P. Fruehauf Targeted therapy in ovarian cancer J Oncol 2010 2010 740472
4. M.K. Hassan, H. Watari, L. Christenson, S. Bettuzzi, and N. Sakuragi Intracellular clusterin negatively regulates ovarian chemoresistance: compromised expression sensitizes ovarian cancer cells to paclitaxel Tumour Biol 32 2011 1031 1047
5. M.D. Jansson, and A.H. Lund MicroRNA and cancer Mol Oncol 6 2012 590 610
6. T.A. Farazi, J.I. Hoell, P. Morozov, and T. Tuschl MicroRNAs in human cancer Adv Exp Med Biol 774 2013 1 20
7. D.A. Chistiakov, and V.P. Chekhonin Contribution of microRNAs to radio- and chemoresistance of brain tumors and their therapeutic potential Eur J Pharmacol 684 2012 8 18
8. F. O'Kelly, L. Marignol, A. Meunier, T.H. Lynch, A.S. Perry, and D. Hollywood MicroRNAs as putative mediators of treatment response in prostate cancer Nat Rev Urol 9 2012 397 407
9. R. Garzon, S. Liu, and M. Fabbri et al. MicroRNA-29b induces global DNA hypomethylation and tumor suppressor gene reexpression in acute myeloid leukemia by targeting directly DNMT3A and 3B and indirectly DNMT1 Blood 113 2009 6411 6418
10. A. Budhu, H.L. Jia, and M. Forgues et al. Identification of metastasis-related microRNAs in hepatocellular carcinoma Hepatology 47 2008 897 907
11. A. Fendler, and K. Jung MicroRNAs as new diagnostic and prognostic biomarkers in urological tumors Crit Rev Oncog 18 2013 289 302
12. M.V. Iorio, R. Visone, and G. Di Leva et al. MicroRNA signatures in human ovarian cancer Cancer Res 67 2007 8699 8707
13. R. Flavin, P. Smyth, and C. Barrett et al. miR-29b expression is associated with disease-free survival in patients with ovarian serous carcinoma Int J Gynecol Cancer 19 2009 641 647
14. J.L. Mott, S. Kobayashi, S.F. Bronk, and G.J. Gores mir-29 regulates Mcl-1 protein expression and apoptosis Oncogene 26 2007 6133 6140
15. K. Shigemasa, O. Katoh, and Y. Shiroyama et al. Increased MCL-1 expression is associated with poor prognosis in ovarian carcinomas Jpn J Cancer Res 93 2002 542 550
16. F. Dai, Y. Zhang, X. Zhu, N. Shan, and Y. Chen The anti-chemoresistant effect and mechanism of MUC1 aptamer-miR-29b chimera in ovarian cancer Gynecol Oncol 131 2013 451 459
17. P. Huang, J. Han, and L. Hui MAPK signaling in inflammation-associated cancer development Protein Cell 1 2010 218 226
18. K.H. Yoo, Y.K. Park, H.S. Kim, W.W. Jung, and S.G. Chang Identification of MAPK10 as a novel epigenetic marker for chromophobe kidney cancer Pathol Int 61 2011 52 54
19. H. Seca, R.T. Lima, V. Lopes-Rodrigues, J.E. Guimaraes, G.M. Almeida, and M.H. Vasconcelos Targeting miR-21 induces autophagy and chemosensitivity of leukemia cells Curr Drug Targets 14 2013 1135 1143
20. A. Budhu, H.L. Jia, and M. Forgues et al. Identification of metastasis-related microRNAs in hepatocellular carcinoma Hepatology 47 2008 897 907
21. A. Laios, S. O'Toole, and R. Flavin et al. Potential role of miR-9 and miR-223 in recurrent ovarian cancer Mol Cancer 7 2008 35
22. K. Kuramoto, A. Sakai, and K. Shigemasa et al. High expression of MCL1 gene related to vascular endothelial growth factor is associated with poor outcome in non-Hodgkin's lymphoma Br J Haematol 116 2002 158 161
23. A.K. Mylin, T. Rasmussen, M. Lodahl, I.M. Dahl, and L.M. Knudsen Upregulated MCL1 mRNA expression in multiple myeloma lacks association with survival Br J Haematol 144 2009 961 963
24. Y. Maesako, T. Uchiyama, and H. Ohno Comparison of gene expression profiles of lymphoma cell lines from transformed follicular lymphoma, Burkitt's lymphoma and de novo diffuse large B-cell lymphoma Cancer Sci 94 2003 774 781
25. S. Blenk, J. Engelmann, and M. Weniger et al. Germinal center B cell-like (GCB) and activated B cell-like (ABC) type of diffuse large B cell lymphoma (DLBCL): analysis of molecular predictors, signatures, cell cycle state and patient survival Cancer Inform 3 2007 399 420
26. H.M. Lin, H.C. Tseng, and C.J. Wang et al. Induction of autophagy and apoptosis by the extract of Solanum nigrum Linn in HepG2 cells J Agric Food Chem 55 2007 3620 3628
27. E. Zavodszky, M. Vicinanza, and D.C. Rubinsztein Biology and trafficking of ATG9 and ATG16L1, two proteins that regulate autophagosome formation FEBS Lett 587 2013 1988 1996
28. S. Wu, X. Wang, J. Chen, and Y. Chen Autophagy of cancer stem cells is involved with chemoresistance of colon cancer cells Biochem Biophys Res Commun 434 2013 898 903